Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation

Supportive Care in Cancer

Volumn 6, Issue 4, 1998, Pages 378-383

  Larsson, K ^a   Bjorkstrand B ^a   Ljungman, P ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Autologous transplantation; Bone marrow; Infectious complications; Peripheral stem cells

Indexed keywords

COLONY STIMULATING FACTOR; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BREAST CANCER; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUTROPENIA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION;

EID: 0031817288     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050180     Document Type: Article

References (19)

1. Ayash LJ, et al (1994) Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer. a feasibility study. J Clin Oncol 12:31-44
2. Barlogie B, et al (1993) Hematopoietic stem cell transplants for multiple myeloma. Leukemia 7:1095
3. Barlogie B, Fernand JP, Henon P, Jagannath S (1993) Peripheral blood stem cell transplants in multiple myeloma. In: Gale RP (ed) Blood stem cell transplants. Cambridge University Press, Cambridge
4. Barlogie B, Jagannath S (1992) Autotransplants in myeloma. Bone Marrow Transplant 10 [Suppl 1]:37-44
5. Björkstrand B, Ljungman P, Bird JM, Samson D, Gahrton G (1995) Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remission in multiple myeloma. Bone Marrow Transplant 15:367-371
6. Chi KH, et al (1995) Effect on granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil and leukovorin chemotherapy. J Clin Oncol 13:2620-2628
7. Demetri GD, Amman KHS (1992) Granulocyte-macrophage colony stimulating factor (GM-CSF): preclinical and clinical investigations. Semin Oncol 19:362-385
8. Gianni AM, Siena S, Bregni M, et al (1989) Granulocyte-macrophage colony-stimulating factor to harvest circulating haematopoetic stem cells for autotransplantation. Lancet 11:580-585
9. Gisselbrecht C, Prentice HG, Bacigalupo A, et al (1994) Placebo-controlled phase III trial of lenograstim in bone marrow transplantation. Lancet 343:696-700
10. Glapsy JA, Golde DW (1992) Gramilocyte colony-stimulating factor (G-CSF): preclinical and clinical studies. Semin Oncol 19:386-394
11. Jagannath S, Vesole DH, Glenn L, Crowely J, Barlogie B (1992) Low risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 80:1666-1672
12. Lopez-Brea M, Lopez E, Paz-Ares L, Hitt R, Garcia-Ribas I, et al (1995) Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors. J Natl Cancer Inst 87:803-808
13. McMillan AK, et al (1990) High dose chemotherapy with autologous bone marrow transplantation in acute myeloid leukemia. Blood 76:480-488
14. Nichols CR, Tricot G, Williams SD (1989) Dose-intensive chemotherapy in refractory germ cell cancer - a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation. J Clin Oncol 7:932-939
15. Peters WP (1991) High-dose chemotherapy and autologous bone marrow support for breast cancer. Important Adv Oncol: 135-150
16. Spitzer G, Adkins DR, Spencer V, et al (1994) Randomized study of growth factors post-peripheral-blood-stem-cell transplant: neutrophil recovery is improved with modest clinical benefit. J Clin Oncol 12:661-670
17. Tricot G, Jagannath S, Vesole D, Nelson J, Tindle S, Miller L, Cheson B, Crowley J, Barlogie B (1995) Peripheral blood stem cell transplants for multiple myeloma: identification of favourable variables for rapid engraftment in 225 patients. Blood 85:588-596
18. Ventura GJ, Barlogie B, Hester JP, et al (1990) High dose cyclophosphamide, BCNU and VP-1,6 with autologous blood stem cell support for refractory multiple myeloma. Bone Marrow Transplant 5:265-268
19. Beveridge RA, Miller JA, Kales AN et al. (1997) Randomized trial comparing the tolerability of sargramostim (yeast-derived RhuGM-CSF) and filgrastim (bacteria-derived RhuG-CSF) in cancer patients receiving myelosuppressive chemotherapy. Support Care Cancer 5:289-298